IntelGenx Technologies Corp. (IGXT)
IGXT Stock Price Chart
Explore IntelGenx Technologies Corp. interactive price chart. Choose custom timeframes to analyze IGXT price movements and trends.
IGXT Company Profile
Discover essential business fundamentals and corporate details for IntelGenx Technologies Corp. (IGXT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Jan 2007
Employees
48.00
Website
https://www.intelgenx.comCEO
Tommy Kenny
Description
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.
IGXT Financial Timeline
Browse a chronological timeline of IntelGenx Technologies Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 13 May 2025
Earnings released on 19 Mar 2025
Earnings released on 7 Nov 2024
Earnings released on 12 Aug 2024
Earnings released on 15 May 2024
EPS came in at -$0.02 , while revenue for the quarter reached $174.00K , missing expectations by -99.44%.
Earnings released on 21 Mar 2024
EPS came in at -$0.02 , while revenue for the quarter reached $426.00K .
Earnings released on 9 Nov 2023
EPS came in at -$0.01 , while revenue for the quarter reached $318.00K .
Earnings released on 14 Aug 2023
EPS came in at -$0.02 , while revenue for the quarter reached $133.00K .
Earnings released on 11 May 2023
EPS came in at -$0.02 , while revenue for the quarter reached $162.00K .
Earnings released on 29 Mar 2023
EPS came in at -$0.02 , while revenue for the quarter reached $173.00K .
Earnings released on 10 Nov 2022
EPS came in at -$0.02 matching the estimated -$0.02, while revenue for the quarter reached $142.00K .
Earnings released on 11 Aug 2022
EPS came in at -$0.02 matching the estimated -$0.02, while revenue for the quarter reached $398.00K .
Earnings released on 12 May 2022
EPS came in at -$0.02 matching the estimated -$0.02, while revenue for the quarter reached $237.00K , beating expectations by +21.21%.
Earnings released on 24 Mar 2022
EPS came in at -$0.02 , while revenue for the quarter reached $494.00K , beating expectations by +147.00%.
Earnings released on 11 Nov 2021
EPS came in at -$0.01 , while revenue for the quarter reached $593.00K , beating expectations by +48.25%.
Earnings released on 4 Aug 2021
EPS came in at -$0.02 , while revenue for the quarter reached $162.00K .
Earnings released on 13 May 2021
EPS came in at -$0.02 , while revenue for the quarter reached $286.00K , missing expectations by -28.50%.
Earnings released on 25 Mar 2021
EPS came in at -$0.02 , while revenue for the quarter reached $790.00K .
Earnings released on 12 Nov 2020
EPS came in at -$0.01 , while revenue for the quarter reached $510.00K .
IGXT Stock Performance
Access detailed IGXT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.